Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, Rötig A, Mayaux MJ, Delfraissy JF.

Lancet. 1999 Sep 25;354(9184):1084-9.

PMID:
10509500
2.
3.

Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.

Thorne C, Newell ML.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):425-36. Review.

PMID:
15010553
4.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
5.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
6.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(2):CD003510. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003510.

PMID:
12076484
7.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Brocklehurst P, Volmink J.

Cochrane Database Syst Rev. 2002;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD003510.

PMID:
11869666
8.

A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.

Newell ML, Gibb DM.

Drug Saf. 1995 Apr;12(4):274-82. Review.

PMID:
7646826
9.

HIV and mitochondrial toxicity in children.

Foster C, Lyall H.

J Antimicrob Chemother. 2008 Jan;61(1):8-12. Epub 2007 Nov 13. Review.

PMID:
17999978
10.

Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.

Poirier MC, Gibbons AT, Rugeles MT, Andre-Schmutz I, Blanche S.

Curr Opin Pediatr. 2015 Apr;27(2):233-9. doi: 10.1097/MOP.0000000000000193. Review.

11.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
12.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
13.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
14.

[Antiretroviral agents and pregnancy: mitochondrial dysfunction and nucleoside analogs].

Loubeyre-Unique C, Gautier A, Vauzelle-Gardier C, Champart AM, Bavoux F.

Therapie. 2001 May-Jun;56(3):261-6. Review. French.

PMID:
11475805
15.

[Reducing perinatal transmission by antiretroviral therapy].

Schmied B.

Wien Med Wochenschr. 1998;148(23-24):550-5. Review. German.

PMID:
10189685
16.

[HIV and pregnancy: risks of transmission and therapeutic possibilities].

Ibe M, Knolle P, Beck T, Meyer zum Büschenfelde KH, Gerken G.

Gynakol Geburtshilfliche Rundsch. 1996;36(4):188-93. Review. German.

PMID:
9206551
17.

[Tolerance of antiretroviral drugs during pregnancy].

Blanche S, Warszawski J.

Med Sci (Paris). 2013 Apr;29(4):383-8. doi: 10.1051/medsci/2013294011. Epub 2013 Apr 26. Review. French.

18.

Supplemental Content

Support Center